190results about "Pneumothorax apparatus" patented technology

The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.

The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.

A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter / one-way valve and an air carrying conduit. In various embodiments, the system may be intrathoracic, extrathoracic or a combination thereof. A pulmonary decompression device may also be utilized to remove trapped air in the lung or lungs, thereby reducing the volume of diseased lung tissue. A lung reduction device may passively decompress the lung or lungs. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal and various devices and / or drugs, agents and / or compounds may be utilized to accelerate wound healing in thoracic anastomosis applications.

A single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. In a single-phase technique the pleurodesis is formed at the same time as the pneumostoma and does not require a separate step. The thoracic cavity is accessed to visualize the lung, the pneumostomy catheter is inserted into the lung and then the lung is secured to the channel through the chest wall creating a sealed anastomosis which matures into a pleurodesis after the procedure.

A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma and for additional patient care utilizing a pneumostoma. The system utilizes a number of modalities to assess the health and functionality of the pneumostoma, the lungs and / or the patient as a whole. In response to an assessment of the health and functionality of the pneumostoma, lungs and patient, the tissues of pneumostoma may be treated with a treatment device and utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma and / or treat other conditions of the patient.

An accelerated two-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. The first phase includes creation of a localized pleurodesis. The localized pleurodesis is created using chemical agents and / or mechanical fasteners to secure the visceral membrane to the pleural membrane. The second phase includes introduction of a surgical instrument into the lung via the pleurodesis to create the pneumostoma. The first and second phases are performed as parts of a single surgical procedure. The formation of a stable pleurodesis is to prevent pneumothorax during the procedure.

A medical device including a portion similar to a Veress needle, useful for relief of tension pneumothorax. The device includes a hollow tubular stylet disposed movably within a hollow needle or cutting cannula, and an optionally releasable locking mechanism for keeping the stylet in place protruding distally beyond the sharpened distal end of the cutting cannula to prevent puncture of internal organs after the chest wall has been intentionally punctured. The stylet can also be moved outward from within the cannula to push a plug of tissue from the bore of the cannula. A valve or a connector for a tube may be provided at a proximal end of the stylet.

A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter / valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma.

A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter / valve to control flow of materials through the tube. The flange is a thin flexible patch which conforms and attaches to the chest of the patient. The flange secures the tube in position in the pneumostoma. The flange is formed in one piece with the tube.

A pneumostoma management system includes a pneumostoma management device for maintaining the patency of a pneumostoma and a drug delivery device for pneumostoma care. The drug delivery device includes a therapeutic agent dispenser for supplying a therapeutic agent and a propellant at positive pressure, a tube for entering the pneumostoma and a limiting device for limiting the depth of insertion of the tube into a pneumostoma. The drug delivery device may be used to introduce therapeutic agents into the pneumostoma for direct treatment of the pneumostoma, treatment of the lung by way of collateral ventilation, and / or treatment of non-lung tissues by diffusion into the bloodstream.

A percutaneous single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. A pneumostomy instrument is introduced percutaneously through the thoracic wall, parietal membrane, visceral membrane and into the parenchymal tissue of the lung. The pneumostomy instrument crosses the pleural cavity between the parietal membrane and visceral membrane there being no pleurodesis between the membranes prior to passage of the pneumostomy instrument. A pneumoplasty device at the distal end of the pneumostomy instrument displaces and engages the parenchymal tissue of the lung and the pneumostomy instrument is used to secure the lung and visceral membrane in contact with the parietal membrane and chest wall. The pneumostomy instrument is left in place while a pneumostoma tract heals and pleurodesis occurs between the pleural membranes surrounding the pneumostomy instrument.

A pneumostoma management system includes a pneumostoma management device for maintaining the patency of a pneumostoma and a drug delivery device for pneumostoma care. The drug delivery device may be used to introduce therapeutic agents into the pneumostoma for direct treatment of the pneumostoma, treatment of the lung by way of collateral ventilation, and / or treatment of non-lung tissues by diffusion into the bloodstream. The drug delivery device includes a therapeutic agent dispenser for supplying a therapeutic agent and a propellant at positive pressure, an outlet and a connector for correctly positioning the outlet relative to a pneumostoma management device. The drug delivery device includes a self-centering and self-sealing connector for engaging the pneumostoma management device.

A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes flange attaches to the chest of the patient to secure the device in position. The pneumostoma management device also includes a tube which enters the pneumostoma to allow gases to escape the lung. The length of the tube is selected to match the dimensions of the pneumostoma of a patient. In order to manufacture devices having different tube lengths, the tube is formed at a longer length than required, cut to size and tipped. The tube may be formed by molding or extrusion.

A method and device are provided for simultaneously or near-simultaneously diagnosing and treating tension pneumothorax and / or hemothoraxA Veress-type needle portion includes a hollow needle for puncturing the chest wall over a blunt hollow probe biased by one or more springs to extend distally into the pleural cavity. Openings in the blunt hollow probe connect via a pathway to an automatic check valve, which permits the flow of air and / or fluid only in a proximal direction. Pressure from within the pleural cavity is transmitted to the interior surface of a pressure documenter. If pressure greater than atmospheric pressure is present in the pleural cavity, the pressure documenter will be automatically urged proximally to simultaneously allow air and / or fluid to escape from the pleural space through the device, thus treating the tension pneumothorax and / or hemothorax, as well as providing a stable indicator to positively document the diagnosis of increased pressure.

Surgical instruments and techniques are provided for creating a pneumostoma through the chest wall into the lung of a patient. The pneumostomy instruments and techniques may be used to create a pneumostoma which allows gases to escape from the lung through the chest wall and thereby treat chronic obstructive pulmonary disease.

A flexible pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management device includes a pneumostoma vent having a tube which enters the pneumostoma to allow gases to escape the lung, a flange and a filter / valve to control flow of materials through the tube. The flange is a thin flexible patch comprises of multiple thin layers of materials and which conforms and attaches to the chest of the patient. The flange includes a filter, a protective outer layer and an inner hydrocolloid layer. The flange secures the tube in position in the pneumostoma.

A method for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. To use the system, the chest is first cleaned and the chest mount secured to the chest adjacent the pneumostoma. The pneumostoma vent is then inserted into the pneumostoma through an aperture in the chest mount until it is engaged and secured by a coupling of the chest mount. The pneumostoma vent may be replaced periodically such as daily. The chest mount may be changed less frequently such as weekly.

A method for treating a pneumostoma by applying suction to the pneumostoma in order to remove solid or liquid discharge. A pneumostoma aspirator including a bulb or syringe is used to apply negative pressure to a tube which enters the pneumostoma. The pneumostoma aspirator may be used in conjunction with a pneumostoma management device. Alternatively, the pneumostoma aspirator may be used after the pneumostoma management device has been removed. The pneumostoma aspirator may also be used to introduce irrigation fluid into the pneumostoma and / or remove irrigation fluid and discharge from the pneumostoma.

A two-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease The first phase is a procedure to induce creation of a localized pleurodesis and is preferably performed as an outpatient procedure. The second phase is a procedure to introduce a surgical instrument into the lung via the pleurodesis to create the pneumostoma. An interval of about one of more days between the first and second phases allows the formation of a stable pleurodesis to prevent pneumothorax during the procedure.

A pneumostoma management device for maintaining the patency of a pneumostoma while controlling the flow of gases and discharge through the pneumostoma. The pneumostoma management device includes a bulb connected to a tube which enters the pneumostoma. A flow control device regulates air flow in and out of the pneumostoma via the tube. A hydrophobic filter traps discharge in the bulb while allowing gases to escape.

A pneumostoma management system for maintaining the patency of a pneumostoma while controlling the flow of material through the pneumostoma. The pneumostoma management system includes a two-part pneumostoma management device and associated insertion and removal tools. The pneumostoma management device includes a pneumostoma vent and a chest mount for positioning and securing the vent into a pneumostoma. The pneumostoma vent includes a hydrophobic filter and / or a one-way valve.

Surgical instruments and techniques are provided for creating a pneumostoma through the chest wall into the lung of a patient. The pneumostomy instruments and techniques may be used to create a pneumostoma which allows gases to escape from the lung through the chest wall and thereby treat chronic obstructive pulmonary disease.

A partially-implantable pneumostoma management device maintains the patency of a pneumostoma while controlling the flow of material through the pneumostoma. A tube of the pneumostoma management device is placed through the chest wall into the lung. The tube comprises a plurality of holes in the distal end to allow the entry of gases and non-gaseous discharge from the lung. A contact surface prevents over-insertion of the tube while releasably securing the device to the chest of the patient. The contact surface has features to reduce irritation of the skin of the chest.

The invention relates to a medical needle which is applicable to a drainage treatment of pneumothorax, in particular to tensive pneumothorax, and is applicable to the drainage treatment of pleural effusion. The invention adopts the technical proposal that: the needle is a disposable thorax drainage needle; a cavity is arranged in a drainage conduit port base which is provided with a side drainage conduit that is connected with the base, extends to the outside and is communicated with a drainage conduit; one end of the side drainage conduit, which is connected with the drainage conduit port base, is positioned at the front end of the cavity; the tail end of the side drainage conduit is provided with at least a port which is provided and connected with an emergency end cover that is a unidirectional gas valve; by adopting the technical proposal, the invention provides a disposable thorax drainage needle which is applicable to pneumothorax drainage treatment, in particular to tensive pneumotharox, and is applicable to the drainage treatment of pleural effusion, and the needle is not easy to damage intercostal vessels in puncturing and drains gas rapidly.

The invention discloses a thoracic anti-blocking drainage apparatus for thoracic surgery. The drainage apparatus comprises an accommodating box and a drainage tube, wherein an air pressure sensor is fixed to the upper side of the inner wall of the accommodating cavity (the accommodating box); a negative-pressure pump is fixed to the upper surface of the accommodating cavity; an air intake end of the negative-pressure pump communicates with one end of an air intake tube, and the other end of the air intake tube runs through and extends to the interior of the accommodating box; a holding box is fixedly arranged on the left side face of the accommodating cavity; a single chip, an electrical control switch and a storage battery are fixedly arranged in the holding box sequentially from top to bottom; a liquid inlet of the accommodating cavity communicates with a liquid outlet cavity of the drainage tube by virtue of a liquid guide tube; a check valve is arranged on the liquid guide tube; the single chip is electrically connected to the electrical control switch, the storage battery and the air pressure sensor; a fixing plate and an airbag cooperate for use, so that a tube body, which stretches into a human body, is prevented from shaking due to movement of an external apparatus, and pain in a patient is prevented; and the interior of the tube body is divided into two areas, namely a liquid inlet cavity and the liquid outlet cavity, so that human body infection caused by waste solutions is prevented and medical safety is guaranteed.

A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma and for additional patient care utilizing a pneumostoma. The system utilizes a number of modalities to assess the health and functionality of the pneumostoma, the lungs and / or the patient as a whole. In response to an assessment of the health and functionality of the pneumostoma, lungs and patient, the tissues of pneumostoma may be treated with a treatment device and utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma and / or treat other conditions of the patient. Particular treatment modalities may be utilized to reduce tissue growth in and around the pneumostoma in order to prevent stenosis and maintain patency of the pneumostoma.

An improved method and device are provided for forming and / or maintaining a percutaneous access pathway. The device generally comprises at least one of three type of components: access pathway, insertion device, and attachment device. In one embodiment, the device is used to form and / or maintain a percutaneous access pathway into the pleural cavity (i.e. tube thoracostomy). The provided assembly substantially reduces the possibility of iatrogenic infection while accessing and / or re-accessing a body space.

A chest seal for treating an open pneumothorax that is low profile and thus unobtrusive so that the chest seal can be effectively maintained in position to seal a chest wound while allowing the pleural cavity to vent.

Methods for creating an anastomosis between a channel through the chest wall and an opening in the visceral membrane of a lung using a medical device. The methods include creating the channel through the chest wall into the pleural cavity; forming an adhesion between the chest wall and the visceral membrane of the lung; creating an opening in the visceral membrane of the lung which communicates with the channel; and inserting the medical device into the channel. The medical device has a compression structure which spans the channel. The methods include configuring the compression structure to apply a compressive force to tissue surrounding the anastomosis and / or applying agents and materials to the tissue of the anastomosis thereby accelerating the formation and healing of the anastomosis.